Visual Evoked Potentials in Patients with Graves' Ophthalmopathy Complicated by Ocular Hypertension and Suspect Glaucoma or Dysthyroid Optic Neuropathy

Overview

Journal Doc Ophthalmol

Specialty Ophthalmology

Date 2003 Apr 8

PMID 12678273

Citations 13

Authors

Gennaro Ambrosio

Giuseppe Ferrara

Raffaella Vitale

Rocco De Marco

Affiliations

Soon will be listed here.

Abstract

The study compared visual evoked potentials of patients with uncomplicated Graves' ophthalmopathy, patients with ophthalmopathy and elevated intraocular pressure or suspect glaucoma, and patients with dysthyroid optic neuropathy (DON). The aim of the study was to investigate the clinical potential for the visual evoked potentials (VEP) in the differential diagnosis among the groups. The VEPs were obtained from 43 subjects with endocrine ophthalmopathy. Group I included patients with uncomplicated ophthalmopathy (30 eyes); group II included patients with ophthalmopathy, intraocular pressure > or = 23 mmHg with and without early visual field defects, and no evidence of apical crowding on coronal computed tomography scan (28 eyes); group III included patients with DON (28 eyes). Amplitude and latency of major component of pattern VEP were obtained at three visual angles (60', 30', 15'). Data from each group was compared with data from age-matched normal subjects. Disturbances of VEP were found mainly in patients of Group II and Group III. Control Group had normal VEP. About the differential diagnosis between Group II and Group III the most important parameter was the N75-P100 amplitude for 15' of pattern stimulation. Only for this visual angle, Group II and Group III had not overlapped N75-P100 amplitude. This study shows that VEP detect visual function abnormalities noninvasively in patients with complicated Graves' ophthalmopathy. Results also indicate the clinical potential for VEP in the differential diagnosis between patients suffering from ophthalmopathy complicated by ocular hypertension or suspect glaucoma and patients with dysthyroid optic neuropathy.

Citing Articles

Restoration of vision by combined experimental antithymocyte therapy, and orbital radiation with high-dose steroids for severe, acute, steroid-refractory, congestive thyroid orbitopathy.

Sarnat-Kucharczyk M, Pojda-Wilczek D, Swierkot M, Kulawik G, Mrukwa-Kominek E Doc Ophthalmol. 2023; 148(1):47-55.

PMID: 37775645 PMC: 10879228. DOI: 10.1007/s10633-023-09955-6.

Functional and Morphological Changes in the Visual Pathway in Patients with Graves' Orbitopathy.

Jagiello-Korzeniowska A, Baldys-Waligorska A, Hubalewska-Dydejczyk A, Romanowska-Dixon B J Clin Med. 2022; 11(14).

PMID: 35887859 PMC: 9318671. DOI: 10.3390/jcm11144095.

Clinical electrophysiology of the optic nerve and retinal ganglion cells.

Marmoy O, Viswanathan S Eye (Lond). 2021; 35(9):2386-2405.

PMID: 34117382 PMC: 8377055. DOI: 10.1038/s41433-021-01614-x.

Early macular and peripapillary vasculature dropout in active thyroid eye disease.

Jamshidian Tehrani M, Mahdizad Z, Kasaei A, Fard M Graefes Arch Clin Exp Ophthalmol. 2019; 257(11):2533-2540.

PMID: 31444554 DOI: 10.1007/s00417-019-04442-8.

Flow Changes in Orbital Vessels Detected with Color Doppler Ultrasound in Patients with Early Dysthyroid Optic Neuropathy.

Lesin M, Rogosic V, Vanjaka Rogosic L, Barisic I, Pelcic G Acta Clin Croat. 2018; 57(2):301-306.

PMID: 30431723 PMC: 6532009. DOI: 10.20471/acc.2018.57.02.10.

References

Janaky M, Benedek G . Visual evoked potentials during the early phase of optic nerve compression in the orbital cavity. Doc Ophthalmol. 1992; 81(2):197-208. DOI: 10.1007/BF00156009. View

Skalka H . Comparison of Snellen acuity, VER acuity, and Arden grating scores in macular and optic nerve diseases. Br J Ophthalmol. 1980; 64(1):24-9. PMC: 1039342. DOI: 10.1136/bjo.64.1.24. View

Greenstein V, Seliger S, Zemon V, Ritch R . Visual evoked potential assessment of the effects of glaucoma on visual subsystems. Vision Res. 1998; 38(12):1901-11. DOI: 10.1016/s0042-6989(97)00348-9. View

Jacobson D, Gorman C . Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment. Endocr Rev. 1984; 5(2):200-20. DOI: 10.1210/edrv-5-2-200. View

HARDING G, Odom J, Spileers W, Spekreijse H . Standard for visual evoked potentials 1995. The International Society for Clinical Electrophysiology of Vision. Vision Res. 1996; 36(21):3567-72. DOI: 10.1016/0042-6989(96)00125-3. View

Trobe J, Glaser J, Laflamme P . Dysthyroid optic neuropathy. Clinical profile and rationale for management. Arch Ophthalmol. 1978; 96(7):1199-1209. DOI: 10.1001/archopht.1978.03910060033007. View

Iester M, Altieri M, Capris P, ZINGIRIAN M, Traverso C . Comparison between relative dispersion analysis of high-pass resolution perimetry and standard threshold perimetry. Eye (Lond). 2000; 14 Pt 5:742-6. DOI: 10.1038/eye.2000.195. View

WERNER S . Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab. 1977; 44(1):203-4. DOI: 10.1210/jcem-44-1-203. View

Ambrosio G, De Marco R, Loffredo L, Magli A . Visual dysfunction in patients with mitochondrial myopathies. I. Electrophysiologic impairments. Doc Ophthalmol. 1995; 89(3):211-8. DOI: 10.1007/BF01203374. View

10.

Neigel J, Rootman J, BELKIN R, Nugent R, Drance S, Beattie C . Dysthyroid optic neuropathy. The crowded orbital apex syndrome. Ophthalmology. 1988; 95(11):1515-21. DOI: 10.1016/s0161-6420(88)32978-7. View

11.

Jamsen K . Thyroid disease, a risk factor for optic neuropathy mimicking normal-tension glaucoma. Acta Ophthalmol Scand. 1996; 74(5):456-60. DOI: 10.1111/j.1600-0420.1996.tb00598.x. View

12.

Leone Jr C . The management of ophthalmic Graves' disease. Ophthalmology. 1984; 91(7):770-9. DOI: 10.1016/s0161-6420(84)34221-x. View

13.

Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S . Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci. 1999; 40(11):2520-7. View

14.

Ohtsuka K . Intraocular pressure and proptosis in 95 patients with Graves ophthalmopathy. Am J Ophthalmol. 1997; 124(4):570-2. DOI: 10.1016/s0002-9394(14)70883-9. View

15.

Manor R, Kurz O, Lewitus Z . Intraocular pressure in endocrinological patients with exophthalmos. Ophthalmologica. 1974; 168(4):241-52. DOI: 10.1159/000307046. View

16.

Tsaloumas M, Good P, Burdon M, Misson G . Flash and pattern visual evoked potentials in the diagnosis and monitoring of dysthyroid optic neuropathy. Eye (Lond). 1994; 8 ( Pt 6):638-45. DOI: 10.1038/eye.1994.159. View

17.

Fells P . Orbital decompression for severe dysthyroid eye disease. Br J Ophthalmol. 1987; 71(2):107-11. PMC: 1041099. DOI: 10.1136/bjo.71.2.107. View

18.

Hallin E, Feldon S . Graves' ophthalmopathy: II. Correlation of clinical signs with measures derived from computed tomography. Br J Ophthalmol. 1988; 72(9):678-82. PMC: 1041555. DOI: 10.1136/bjo.72.9.678. View

19.

SETALA K, Raitta C, Valimaki M, Katevuo V, LAMBERG B . The value of visual evoked potentials in optic neuropathy of Graves' disease. J Endocrinol Invest. 1992; 15(11):821-6. DOI: 10.1007/BF03348812. View